Schedule 13G ownership disclosure
ONCOCYTE CORPORATION
Common Shares, No Par Value · CUSIP: 68235C107
Event date: 2025-02-10
- Filing-level shares
- 2,764,078.00
- Percent of class
- 9.7%
- BIO-RAD LABORATORIES, INC
Shares: 2,764,078.00 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000012208-25-000014
- Form type
- SCHEDULE 13G/A
- Filer
- BIO-RAD LABORATORIES, INC.
- CIK
- CIK 12208
- Filed
- Mar 04, 2025
- Reporting period
- Feb 10, 2025
- Description
- Schedule 13G beneficial ownership